Beneficial role of ferulic acid supplementation on lipid profile status in streptozotocin-induced diabetic rats

Sudha Anjali, K. G. Padmakumaran Nair, Sukanta Mondal, Saraswathy Mini
{"title":"Beneficial role of ferulic acid supplementation on lipid profile status in streptozotocin-induced diabetic rats","authors":"Sudha Anjali, K. G. Padmakumaran Nair, Sukanta Mondal, Saraswathy Mini","doi":"10.31989/ffs.v3i11.1256","DOIUrl":null,"url":null,"abstract":"Background: Diabetes is a chronic metabolic disorder marked by persistent elevated blood sugar concentrations and disturbances in the metabolism of carbohydrates, lipids, and proteins. Several functional foods and naturally occurring compounds derived from plants have therapeutic potential for managing diabetes and its associated metabolic abnormalities of lipids. Ferulic acid is a bioactive compound present in numerous functional foods. It provides an extensive array of health advantages, encompassing a diverse spectrum of benefits.Objective:The objective of this study was to assess the effect of 50 mg/kg body weight of Ferulic acid (FA50) on the lipid profile status in diabetic rats induced with Streptozotocin (STZ).Materials and methods: Experimental diabetes was created on male albino Sprague Dawley rats. The rats were categorized into five distinct groups- Normal (Group 1), Normal+ FA50 (Group 2), Diabetic control (Group 3), Diabetic + FA50 (Group 4), and Diabetic + Glibenclamide (Group 5). Diabetes was induced in Group 3, 4, and 5 by administering an I.P (intraperitoneal) injection of STZ (40 mg/kg body weight). Rats of groups 2 and 4 were orally administered with 50 mg of FA per rat’s body weight in Kg. Group 5 was treated with Glibenclamide (5 mg/ Kg body weight) daily for two months. On the 60th day, rats from all groups were euthanized, and blood samples were gathered for the purpose of conducting biochemical assessments.Results: The injection of STZ resulted in a significant increase in blood glucose, HbA1c, and lipid profile markers in the experimental rats. Oral administration of Ferulic acid and Glibenclamide drug to diabetic rats significantly (P ≤ 0.05) lowered hyperglycemia, triglycerides, and total cholesterol compared to the diabetic control group. Moreover, the administration of Ferulic acid significantly increased the levels of HDL-cholesterol and regulated the Apo lipoprotein A1- Apo lipoprotein B levels.Conclusion: The current research demonstrates the advantageous impact of Ferulic acid in improving lipid-related metabolic complications associated with diabetes.Keywords: Nutraceuticals, Ferulic acid, Streptozotocin, Diabetes, Lipid profile","PeriodicalId":12570,"journal":{"name":"Functional Food Science","volume":"145 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Functional Food Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31989/ffs.v3i11.1256","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Diabetes is a chronic metabolic disorder marked by persistent elevated blood sugar concentrations and disturbances in the metabolism of carbohydrates, lipids, and proteins. Several functional foods and naturally occurring compounds derived from plants have therapeutic potential for managing diabetes and its associated metabolic abnormalities of lipids. Ferulic acid is a bioactive compound present in numerous functional foods. It provides an extensive array of health advantages, encompassing a diverse spectrum of benefits.Objective:The objective of this study was to assess the effect of 50 mg/kg body weight of Ferulic acid (FA50) on the lipid profile status in diabetic rats induced with Streptozotocin (STZ).Materials and methods: Experimental diabetes was created on male albino Sprague Dawley rats. The rats were categorized into five distinct groups- Normal (Group 1), Normal+ FA50 (Group 2), Diabetic control (Group 3), Diabetic + FA50 (Group 4), and Diabetic + Glibenclamide (Group 5). Diabetes was induced in Group 3, 4, and 5 by administering an I.P (intraperitoneal) injection of STZ (40 mg/kg body weight). Rats of groups 2 and 4 were orally administered with 50 mg of FA per rat’s body weight in Kg. Group 5 was treated with Glibenclamide (5 mg/ Kg body weight) daily for two months. On the 60th day, rats from all groups were euthanized, and blood samples were gathered for the purpose of conducting biochemical assessments.Results: The injection of STZ resulted in a significant increase in blood glucose, HbA1c, and lipid profile markers in the experimental rats. Oral administration of Ferulic acid and Glibenclamide drug to diabetic rats significantly (P ≤ 0.05) lowered hyperglycemia, triglycerides, and total cholesterol compared to the diabetic control group. Moreover, the administration of Ferulic acid significantly increased the levels of HDL-cholesterol and regulated the Apo lipoprotein A1- Apo lipoprotein B levels.Conclusion: The current research demonstrates the advantageous impact of Ferulic acid in improving lipid-related metabolic complications associated with diabetes.Keywords: Nutraceuticals, Ferulic acid, Streptozotocin, Diabetes, Lipid profile
补充阿魏酸对链脲佐菌素诱导的糖尿病大鼠血脂状况的有益作用
背景:糖尿病是一种慢性代谢性疾病,以持续升高的血糖浓度和碳水化合物、脂质和蛋白质代谢紊乱为特征。几种功能性食品和从植物中提取的天然化合物具有治疗糖尿病及其相关的脂质代谢异常的潜力。阿魏酸是一种生物活性化合物,存在于许多功能性食品中。它提供了一系列广泛的健康优势,包括各种各样的益处。目的:研究50 mg/kg体重阿威酸(FA50)对链脲佐菌素(STZ)诱导的糖尿病大鼠血脂状况的影响。材料与方法:建立雄性白化大鼠实验性糖尿病模型。将大鼠分为正常组(1组)、正常组+ FA50组(2组)、糖尿病对照组(3组)、糖尿病组+ FA50组(4组)、糖尿病组+格列本脲组(5组)。3、4、5组通过腹腔注射STZ (40 mg/kg体重)诱导糖尿病。2、4组大鼠每体重(Kg)口服FA 50 mg。第5组给予格列本脲(5 mg/ Kg体重)每日治疗,疗程2个月。第60天,对各组大鼠实施安乐死,并采集血样进行生化评价。结果:注射STZ可使实验大鼠血糖、糖化血红蛋白、血脂指标明显升高。与糖尿病对照组相比,口服阿威酸和格列本脲类药物可显著降低糖尿病大鼠的高血糖、甘油三酯和总胆固醇(P≤0.05)。此外,阿魏酸显著提高了高密度脂蛋白胆固醇水平,调节了载脂蛋白A1和载脂蛋白B水平。结论:目前的研究表明阿魏酸在改善糖尿病相关脂质代谢并发症方面具有有利作用。关键词:保健品,阿魏酸,链脲佐菌素,糖尿病,血脂
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信